Dear Friends of LRF,
This past year was challenging at best but made one thing very clear: our work together can transform the landscape of lymphoma research and provide critical support to patients and their loved ones when they need it most.
Because of generous supporters like you, we continue to fund the most promising lymphoma researchers and advance our understanding of the more than 100 different lymphoma subtypes. Finding cures truly starts here.
We are excited to start the new year with a new Pulse issue that highlights all the incredible strides made in lymphoma research and how supporters like you make them possible. We profile one of the world’s leading lymphoma clinical researchers, Scientific Advisory Board (SAB) member, and LRF grantee Michael Williams, MD, ScM, of the University of Virginia School of Medicine. Dr. Williams has led the way in furthering our understanding of novel targeted therapies — like oral anti-cancer therapy — and mantle cell lymphoma (MCL), outlining challenges and areas of future study to improve patient outcomes. Dr. Williams’s and other leading lymphoma researchers’ contributions inform our MCL patient education programming and resources and have led us to develop the first-ever resources focused on oral therapies in the treatment of lymphoma and chronic lymphocytic leukemia (CLL).
This issue also features two topics impacting our community: cancer survivorship and managing stress during treatment and a pandemic. We offer numerous resources to patients and their caregivers to address these critical topics highlighted in these important pieces.
We also share updates from the most extensive global scientific conference for lymphoma research and clinicians, the American Society of Hematology Annual Meeting & Exposition. LRF grantees and scientific advisors, supported by LRF funding, presented pivotal data that will inform the development of new therapies across the spectrum of lymphoma subtypes. Many of these studies will be highlighted during LRF patient education programs throughout 2021.
As we look towards a new year of innovation and progress, we will continue to invest in the best and brightest researchers. We will deepen our understanding of lymphoma. And we will continue to support the thousands of people affected by this blood cancer. Thank you for supporting this vital work.
Chief Executive Officer
Read more articles and updates in the latest issue of Pulse
Pulse is a publication of the Lymphoma Research Foundation, providing the latest updates on the Foundation and its focus on lymphoma and chronic lymphocytic leukemia (CLL) research, awareness and education. Read more >